Raymond James Financial
GMAB icon

Raymond James Financial’s Genmab GMAB Stock Holding History

Raymond James Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
66,902
+19,046
+40% +$571K ﹤0.01% 3444
2025
Q4 		$1.49M Buy
47,856
+12,288
+35% +$383K ﹤0.01% 3509
2025
Q3 		$1.09M Buy
35,568
+4,422
+14% +$108K ﹤0.01% 3623
2025
Q2 		$643K Buy
31,146
+10,113
+48% +$208K ﹤0.01% 3847
2025
Q1 		$412K Sell
21,033
-96,969
-82% -$2.03M ﹤0.01% 4048
2024
Q4 		$2.46M Buy
+118,002
New +$2.59M ﹤0.01% 2819

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Raymond James Financial's GMAB Position: Q1 2026 in Review

Raymond James Financial increased its Genmab (GMAB) stake by 40% in Q1 2026, buying an estimated $571K and bringing the position to 66,902 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3444.

Raymond James Financial first reported a position in GMAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.46M in Q4 2024. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Raymond James Financial held 66,902 shares of Genmab worth $1.78M as of Q1 2026.
  • Raymond James Financial bought 19,046 Genmab shares in Q1 2026, an estimated $571K.
  • Genmab made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3444 holding.
  • Raymond James Financial first reported a position in Genmab in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Genmab position peaked at $2.46M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.